Capeval Pharma

CapEval Pharma, founded in 2010, provides pharmaceutical consultancy services from early pre-clinical to clinical development, specifically in the sectors of Safety, Toxicology, Pharmacology, Ophthalmology, ADME/PK, analytical development, QA, CMC-Regulatory Affairs and Compliance. In addition, CapEval provides expert assessment for due diligence, veterinary drugs, cosmetics, agrochemicals and chemicals as well as staff training. Drawing on > 60 years of combined international experience, we are a team of highly qualified pharmaceutical consultants, fluent in 5 languages. We provide scientific advice and training to identify the best approach to move your projects quickly through development and onto the commercial market. With experience working in Biotech, Pharma and CRO sectors, we are uniquely qualified to offer complete outsourcing management services for critical studies and product development. We have extensive experience in due diligence proceedings (>100) providing expert assessment of both in- and out-licensing programs and creating gap analysis, which can be used for determination of project value. We work closely with clients, to help manage key objectives and make an appropriate assessment of regulatory hurdles taking into consideration the evolving requirements of the international regulatory landscape. We can either perform in house studies or monitor outsourced studies.